Beyond the decline of cholinergic activity, the deficits in distribution, production and function of NGF have also been proved to be causative for the abnormal processing of the APP and tau dysmetabolism associated in the CNS with the two prominent clinico-pathological AD hallmarks, i.e., the deposits of Aβ and the tau-positive NFT. The gene discussed is NGF; the disease is Alzheimer disease.